Oleksandr Gryzodub: Difference between revisions
Expand source-linked author records; preserve work-specific attribution |
Add complete multilingual reference and language navigation |
||
| Line 1: | Line 1: | ||
<div class="wiki-language-nav" style="padding:0.75em; border:1px solid #b5c8cd; border-radius:0.5em; margin-bottom:1em;">[[Oleksandr Gryzodub|English]] · [[Oleksandr Gryzodub/uk|Українська]] · [[Oleksandr Gryzodub/es|Español]] · [[Oleksandr Gryzodub/fr|Français]] · [[Oleksandr Gryzodub/de|Deutsch]] · [[Oleksandr Gryzodub/pt|Português]]</div> | |||
'''Oleksandr Gryzodub''' is recorded as an author in the public publication source below. This is a publication-linked research record, not a complete biography. | '''Oleksandr Gryzodub''' is recorded as an author in the public publication source below. This is a publication-linked research record, not a complete biography. | ||
Latest revision as of 00:52, 12 November 2026
Oleksandr Gryzodub is recorded as an author in the public publication source below. This is a publication-linked research record, not a complete biography.
Documented work
Coauthor of a 14 March 2023 paper on pharmacy quality systems and the State Pharmacopoeia of Ukraine.
Research context: Connections between pharmacopoeial standards, pharmaceutical organization and legal frameworks.
Named collaborators on this work: Valentyn Shapovalov.
Identity and evidence notes
The publisher uses Gryzodub; references elsewhere also use Gryzodoub or Grizodoub. This entry uses the linked article identity, not name similarity alone.
Inclusion records authorship of the cited work, not endorsement of every later Vision 2035 proposal. Publication affiliations are historical unless separately updated.
See People and attribution and Research network.